Objectives To quantify the carbon footprint from a sample of pharma industry sponsored phase III trials. To develop an approach that can readily be applied to future trials by AstraZeneca and other trial sponsors. Design Life cycle assessment including all the sources of carbon emissions associated with a completed. an ongoing and a planned clinical trial. https://foldlyers.shop/product-category/mains-hardware/